This Biotech Nearly Tripled Street Expectations For One Key Drug – Investor’s Business Daily


Investor's Business Daily

This Biotech Nearly Tripled Street Expectations For One Key Drug
Investor's Business Daily
... revenue grew 6% though profits sank 3.3%. On the stock market today, Biogen fell 0.6% to close at 282.96, after gaining as much as 4.3% before the open. Shares hit their highest point since April 25 while biotech stocks were generally flat early ...

and more »

Read More

Biotech Movers: Novavax Falls Again After New Data on RSV Vaccine Fails to Excite – TheStreet.com


TheStreet.com

Biotech Movers: Novavax Falls Again After New Data on RSV Vaccine Fails to Excite
TheStreet.com
Shares of vaccine company Novavax Inc. (NVAX) were down 24% to $1.15 early Tuesday afternoon. The Gaithersburg, Md.-based firm after the market close on Monday reported positive topline data from its Phase 2 safety and immunogenicity trial of the RSV ...
Novavax, Inc. - NVAX - Stock Price Today - ZacksZacks Investment Research

all 102 news articles »

Read More

Boosts in R&D Spending Drive Biotech Innovation, BDO USA Analysis Finds – CPAPracticeAdvisor.com


Zacks.com

Boosts in R&D Spending Drive Biotech Innovation, BDO USA Analysis Finds
CPAPracticeAdvisor.com
Fueled by a desire for innovation and new medical breakthroughs, the biotech industry continues to enjoy substantial growth due to increased investment in research and development (R&D), according to the sixth annual study from BDO USA, LLP. The 2017 ...
Biotech ETF Industry Outlook for Second Half 2017Zacks.com

all 2 news articles »

Read More